MedPath

Prospective randomized phase 2 trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy

Not Applicable
Conditions
Patients who need pancreaticoduodenectomy
Registration Number
JPRN-UMIN000011454
Lead Sponsor
Multicenter Clinical Study Group of Osaka
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Severe liver cirrhosis or severe active hepatitis (2) Severe pulmonary disorders (3) Severe renal disorders (4) Active double cancer except carcinoma in situ or intramucosal cancer (synchronous double cancer or asynchronous double cancer with disease-free duration to be within 2 years) (5) Hypersensitivity to eggs (6) As determined by the principal investigator or the sub-investigator the subject is not adequate to participate in the trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath